Shayan Datta
@datta_shayan
Resident doctor, LED CT2 Medicine. Interested in metabolic health, acute care and cardiology (he/him).
Should combination diuretics have a greater role in acute heart failure? A compelling argument by @itsgautamsen #BCS2025 @BritishCardioSo
Awesome overview of obesity pharmacotherapies and HF by @GauravGulsin at #BCS2025 @BritishCardioSo
Excited to share insights from the Brighton Cardio-Oncology team at #BCS2025! 🫀 #CardioOncology #CardioX @BritishCardioSo
Incredible thread!
Prevent Frailty, Prevent Cardiovascular Disease: Early Identification of Patients at Risk: @JACCJournals 🥸 Sorry for away (in transition) and without a desk! 😱 But here is work with @NailaIjaz_MD & @MichaelGNanna on prevention of frailty and CVD! 🥸 Summary 👇👇👇
#SGLT2 inhibitors may slow the progression of nonsevere aortic stenosis, according to a study published in #JACCINT. Learn more: bit.ly/4hOrOmA #vhdAS #cvVHD @JACCJournals
📌Heart Failure with Preserved Ejection Fraction🫀 #Review #NEJM @NEJM #HFpEF
📌Atrial Fibrillation⚡️ Great #Review at @JAMA_current #AFib
Modern RCTs of GDMT in #HFpEF have been well represented with older adults (median age >70y) who carry a high burden of #frailty (upper range of FI>0.50) Reassuringly, evidence supports that frail older adults benefit similarly (or even to a greater degree!) from core #GDMT👇🏾
Efficacy and effectiveness of GDMT demonstrated in frail HF patients ahajournals.org/doi/10.1161/CI… sciencedirect.com/science/articl… pubmed.ncbi.nlm.nih.gov/36050227/
Systematic review Cardiorenal benefits might be magnified with the combination therapy of SGLT2i and GLP-1RA when compared with monotherapy of either agent. dom-pubs.onlinelibrary.wiley.com/doi/full/10.11…
In patients with heart failure with preserved ejection fraction and obesity, treatment with tirzepatide led to a lower risk of death from cardiovascular causes or worsening heart-failure events than placebo. Full SUMMIT trial results: nej.md/4hRGaTY #AHA24
This two-part review explores the critical role of physical activity and cardiorespiratory fitness in preventing and managing atherosclerotic cardiovascular disease...
What I've learned from being a woman in medicine- Chapter 11, Mastering the Art of Patient Care link.springer.com/book/10.1007/9… #kittlesonrules
Obesity is a growing global epidemic with major health consequences. Bariatric surgery is the most effective treatment, with progress in the development of pharmacological agents. However, all obesity treatments have been underutilised. Find out more: hubs.li/Q02SvF3Z0
“There is no need to change the STEMI-NSTEMI paradigm. I never see false negatives.” We published the article “The no false negative paradox in STEMI-NSTEMI diagnosis” in Heart (BMJ), and I’ll explain this paradox with a story: José de Alencar sees a patient with angina. 🧵
The other side of the coin: 🔥🔥🔥Review on Evidence of Cachexia Reversal With HF Medical and Surgical Therapies. #JACCHF @JACCJournals jacc.org/doi/10.1016/j.…
Original Article: Invasive Treatment Strategy for Older Patients with Myocardial Infarction (SENIOR-RITA) nej.md/4fZIG9z #ESCardio | @escardio
Love this - #ESCCongress living up to this year’s theme!
Efficacy and effectiveness of GDMT demonstrated in frail HF patients ahajournals.org/doi/10.1161/CI… sciencedirect.com/science/articl… pubmed.ncbi.nlm.nih.gov/36050227/
The most anticipated skit at the ESC congress! @MedCrisis sharing a bit about William Harvey and how we’ve come a long way from using venesection to treat heart failure. #ESCCongress2024
#ESCCongress and @TheLancet Long live #Semaglutide Now in HFpEF too- 31% reduction in CVD death or HF thelancet.com/journals/lance… @NICEComms time to update your guidance! @DrMarthaGulati @mmamas1973 @AnastasiaSMihai @Hragy @HanCardiomd @justvick @vouvouka @papathanasiou_